This is worrisome if Fulnecky plans to enter medicine. Past behavior predicts future behavior, and rewarding bad behavior ...

Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...

In May 2018, andexanet was granted accelerated approval as the sole antidote on the market for the DOACs rivaroxaban (Xarelto ...

Florida officials are plowing ahead with a proposal to roll back certain vaccine mandates for the state's schoolchildren, after Republican Gov. Ron DeSantis called for the state to become the first in ...

Six-time Olympic cycling champion Chris Hoy's prostate cancer diagnosis, revealed in 2023, put the disease under the ...

A number of diseases tend to peak in the winter, thanks to indoor gatherings that help germs spread. The list includes not ...

Among 22 infants born alive, resuscitation was attempted in 17. Of these, six survived to discharge from the neonatal ...

The risk-based screening strategy was associated with similar detection rates for any cancer compared with annual screening ...

Clinicians face exciting new options in immunoglobulin A (IgA) nephropathy, with recent accelerated FDA approvals and ...

The final Dec. 5 memo, according to FDA employees with knowledge of the situation, states that under an established World ...

Officially lowering the evidentiary bar creates a predictable risk: more companies may highlight their most favorable study while downplaying or withholding less supportive results -- data the public ...